ArticleVaccine2023

Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022.

Meagan C Fitzpatrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.